Assessing the Impact of Fentanyl on Hypoxemia Risk in Upper Gastrointestinal Endoscopy: A Comparative Analysis
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S472-S473
DOI: 10.1055/s-0044-1783898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von E. Klang und 3 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Aims
Sedation plays a pivotal role in ensuring patient comfort and procedure efficacy during upper GI endoscopy. However, the choice of sedative agents is a delicate balance between achieving adequate sedation and minimizing adverse events, particularly hypoxemia. Currently, there are few commonly used sedation protocols. This research aims to compare hypoxemia risk between 2 commonly used protocols .
Methods
We conducted a retrospective analysis at Sheba Medical Center, focusing on adult patients who underwent upper gastrointestinal (UGI) endoscopy between January 2020 and October 2023. Our study specifically targeted patients who received one of two anesthesia regimens: a combination of fentanyl, midazolam, and propofol, or midazolam and propofol without fentanyl. Inclusion criteria were adult patients receiving these specific regimens during UGI endoscopy within the study period. We excluded patients with incomplete data from the analysis. We excluded patients with incomplete data. Data included demographics, clinical assessment scores (ASA and Malampati), medication administration details, and oxygen saturation levels recorded during the procedure. We used the Chi-square test to compare categorical variables and independent t-tests for continuous variables. To assess the association between fentanyl administration and the incidence of hypoxemia (defined as oxygen saturation measurement below 90%), we conducted a logistic regression analysis. This model adjusted for potential confounders including age, ASA score, and Malampati score, providing adjusted odds ratios (aORs) with 95% confidence intervals and p-values Results In our cohort of 14,776 patients undergoing UGI endoscopy, 64.7% (n=9,561) were administered fentanyl along with midazolam and propofol, while the remaining 35.3% (n=5,215) received only midazolam and propofol. The median age in the fentanyl group was 57.3 years (IQR 40.2 – 69.9), significantly younger than the non-fentanyl group at 69.2 years (IQR 56.8 – 76.4, p
Zitieren
APA
Klang, E., Sharif, K., Rahman, N., & Lahat, A. (2024). Assessing the Impact of Fentanyl on Hypoxemia Risk in Upper Gastrointestinal Endoscopy: A Comparative Analysis. Endoscopy, 56(S 02 S 02), S472-S473. https://doi.org/10.1055/s-0044-1783898
Vancouver
Klang E, Sharif K, Rahman N, Lahat A. Assessing the Impact of Fentanyl on Hypoxemia Risk in Upper Gastrointestinal Endoscopy: A Comparative Analysis. Endoscopy. 2024;56(S 02 S 02):S472-S473. doi:10.1055/s-0044-1783898
BibTeX
@article{Klang2024,
author = {Klang, E. and Sharif, K. and Rahman, N. and Lahat, A.},
title = {Assessing the Impact of Fentanyl on Hypoxemia Risk in Upper Gastrointestinal Endoscopy: A Comparative Analysis},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S472--S473},
doi = {10.1055/s-0044-1783898}
}
EUVIMED